Updated March 23 at 4:23pm
Homeland Security
21 results total, viewing 21 - 21
(Updated, Dec. 19, 4:40 p.m.) EpiVax Inc. is part of a team that has been awarded a $1.87 million grant from Department of Defense’s Defense Threat Reduction Agency to develop an effective vaccine against a bacterium that leads to melioidosis, a tropical disease that is resistant to many antibiotics. more
« Prev | 1 | 2 | 3